1
Drug-Drug Interaction Study of Voriconazole With Clarithromycin.
Condition(s):HealthyLast Updated:May 18, 2022Completed
VFEND: 196 Clinical Trials, Page 1 of 20
Hide Studies Not Open or Pending
2
Individualisation of Voriconazole Antifungal Therapy Antifungal Therapy
Condition(s):Immunocompromised Patient; Aspergillosis; FusariumLast Updated:October 7, 2015Suspended
3
Influence of CYP2C19 Genotype on Safety and Efficacy of Voriconazole in Pediatric Patients With Hematologic Malignancy
Condition(s):Adverse Drug ReactionsLast Updated:February 8, 2021Unknown status
4
The Influence of CYP2C19 Polymorphisms on the Safety and Efficacy of Voriconazole
Condition(s):Adverse Drug ReactionsLast Updated:September 16, 2020Unknown status
5
Voriconazole (Vfend) Drug Use Investigation (Regulatory Post Marketing Commitment Plan)
Condition(s):Systemic MycosisLast Updated:August 8, 2013Completed
6
Voriconazole (Vfend) Special Investigation (Regulatory Post Marketing Commitment Plan)
Condition(s):Scedosporium InfectionLast Updated:December 17, 2013Completed
7
The Study of Voriconazole Trough Level in the First Two Weeks After Administration in King Chulalongkorn Memorial Hospital.
Condition(s):Voriconazole; Fungal InfectionLast Updated:August 24, 2017Unknown status
8
Voriconazole for IPA in Chinese Patients With COPD
Condition(s):Invasive Pulmonary Aspergillosis; COPDLast Updated:September 9, 2014Unknown status
9
Non-Interventional Post Marketing Surveillance Study To Observe The Safety And Efficacy Of Vfend® IV
Condition(s):Serious Fungal InfectionsLast Updated:June 7, 2012Completed
10
Pharmacokinetics of Voriconazole in Obese Subjects
Condition(s):HealthyLast Updated:February 9, 2017Completed